Christine Ribic
Overview
Explore the profile of Christine Ribic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
970
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shamseddin M, Paraskevas S, Mainra R, Maru K, Piggott B, Jagusic D, et al.
Can J Kidney Health Dis
. 2024 Dec;
11:20543581241306811.
PMID: 39735689
Purpose: Highly sensitized patients (HSPs) with kidney failure have limited access to kidney transplantation and poorer post-transplant outcomes. Prioritizing HSPs in kidney allocation systems and expanding the pool of deceased...
2.
Uy M, Lam C, Guo Y, Bansal R, Hae R, Gangji A, et al.
Can Urol Assoc J
. 2024 Feb;
18(4):110-114.
PMID: 38381939
Introduction: Postoperative imaging for deceased donor renal transplants is often delayed, as these surgeries occur after-hours. These delays can be critical in identifying immediate complications. To our knowledge, there are...
3.
Somaili M, Jeyakumar N, McArthur E, Ribic C, Sood M, Harel Z, et al.
Transplant Proc
. 2022 Jun;
55(7):1765.
PMID: 35725597
No abstract available.
4.
Somaili M, Jeyakumar N, McArthur E, Ribic C, Sood M, Harel Z, et al.
Transplant Proc
. 2020 May;
52(10):3144-3152.
PMID: 32402459
Background: Kidney transplant recipients (KTRs) are routinely excluded from direct oral anticoagulant (DOAC) trials. Given the lack of safety and efficacy data in this population, we examined real-world prescribing practices...
5.
Lapeyraque A, Bitzan M, Al-Dakkak I, Francis M, Huang S, Kaprielian R, et al.
Can J Kidney Health Dis
. 2020 Feb;
7:2054358119897229.
PMID: 32047641
Background: Atypical hemolytic uremic syndrome (aHUS) is an extremely rare, heterogeneous disease of uncontrolled activation of the alternative complement pathway that is difficult to diagnose. We have evaluated the Canadian...
6.
Bukhari M, Al-Theaby A, Tawhari M, Al-Shaggag A, Pyrke R, Gangji A, et al.
World J Transplant
. 2019 Nov;
9(6):134-144.
PMID: 31750090
Background: Novel oral anticoagulants (NOACs) were developed as alternatives to vitamin K antagonists, primarily warfarin, as they do not require routine monitoring and have limited drug-drug and drug-food interactions. However,...
7.
Risk Factors for 1-Year Graft Loss After Kidney Transplantation: Systematic Review and Meta-Analysis
Foroutan F, Friesen E, Clark K, Motaghi S, Zyla R, Lee Y, et al.
Clin J Am Soc Nephrol
. 2019 Sep;
14(11):1642-1650.
PMID: 31540931
Background And Objectives: With expansion of the pool of kidney grafts, through the use of higher-risk donors, and increased attention to donor management strategies, the 1-year graft survival rate is...
8.
Hildebrand A, Ribic C, Zimmerman D
Ann Intern Med
. 2019 Jul;
171(3):214-215.
PMID: 31307054
No abstract available.
9.
Wang M, Chin-Yee B, Lo C, Lee S, El-Helou P, Alowami S, et al.
Transpl Infect Dis
. 2019 Mar;
21(3):e13077.
PMID: 30873722
Crusted scabies is a rare disease variant associated with T-cell dysregulation. Transplant patients are at risk of developing crusted scabies as a consequence of their immunosuppressive regimens. We report a...
10.
DAragon F, Cook D, Dhanani S, Ribic C, Burns K, Akhtar A, et al.
Can J Anaesth
. 2018 Jul;
65(10):1110-1119.
PMID: 29987806
Purpose: Improving the medical care of deceased organ donors to increase transplant rates and improve allograft function requires an understanding of the current epidemiology and clinical practices of deceased donation...